Characteristics | Total | Alive n = 402 | Death n = 87 | P value |
---|---|---|---|---|
Number (%) | Number (%) | Number (%) | ||
Sex | ||||
Male | 221 (45.2) | 179 (81) | 42 (19) | 0.604 |
Female | 268 (54.8) | 223 (83) | 45 (17) | |
Age groups (years) | ||||
18–29 | 201 (41.1) | 167 (83.1) | 34 (16.9) | 0.937 |
30–39 | 149 (30.5) | 123 (82.5) | 26 (17.5) | |
40–49 | 100 (20.4) | 81 (81) | 19 (19) | |
50+ | 39 (8.0) | 31 (79.5) | 8 (20.5) | |
Nutritional status | ||||
Malnourished | 163 (33.3) | 122 (74.8) | 41 (25.2) | 0.004 |
Non-malnourished | 326 (66.7) | 280 (85.9) | 46 (14.1) | |
Educational status | ||||
No education | 138 (28.2) | 102 (73.9) | 36 (26.1) | 0.011 |
Primary | 164 (33.5) | 138 (84.1) | 26 (15.9) | |
Secondary | 152 (31.1) | 129 (84.9) | 23 (15.1) | |
Tertiary | 35 (7.2) | 33 (94.3) | 2 (5.7) | |
Functional status | ||||
Working | 265 (54.2) | 257 (96.9) | 8 (3.1) | 0.0001 |
Ambulatory | 197 (40.3) | 128 (64.9) | 69 (35.1) | |
Bedridden | 27 (5.5) | 17 (62.9) | 10 (37.1) | |
WHO clinical stage | ||||
Stage I | 48 (9.8) | 47 (97.9) | 1 (2.1) | 0.0001 |
Stage II | 197 (40.3) | 192 (97.5) | 5 (2.5) | |
Stage III | 220 (45) | 149 (67.7) | 71 (32.3) | |
Stage IV | 24 (4.9) | 14 (58.3) | 10 (41.7) | |
Previous OIs | ||||
None | 304 (62.2) | 289 (95.1) | 15 (4.9) | 0.0001 |
One | 68 (13.9) | 50 (73.5) | 18 (26.5) | |
2+ | 117 (23.9) | 63 (53.8) | 54 (46.2) | |
Initial ART regimen | ||||
d4t(30)-3TC-NVP | 83 (17) | 72 (86.7) | 11 (13.3) | 0.245 |
d4t(30)-3TC-EFV | 64 (13.1) | 51 (79.6) | 13 (20.4) | |
AZT-3TC-NVP | 230 (47) | 193 (83.9) | 37 (16.1) | |
AZT-3TC-EFV | 112 (22.9) | 86 (76.8) | 26 (23.2) | |
HIV related counseling | ||||
Yes | 141 (28.8) | 135 (95.7) | 6 (4.3) | 0.0001 |
No | 348 (71.2) | 267 (76.7) | 81 (23.7) | |
TB history | ||||
Yes | 148 (30.3) | 101 (68.2) | 47 (31.8) | 0.0001 |
No | 341 (69.7) | 301 (88.2) | 40 (11.8) |